Delivery Order SPE2DB20D3505-SPE2DB25FT4G8

Award Date 11/14/24
Potential Completion Date 11/15/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB25FT4G8
    Delivery Order

This federal contract award is for the delivery of 4 mg ondansetron hydrochloride tablets to the Defense Logistics Agency (DLA). The $1,149.49 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,149.49 and an ultimate completion date of November 15, 2024.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award appears to be a delivery order against that larger IDC contract. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:16 AM